Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 31.7B | 31.4B | 27.6B | 23.6B |
Cost of revenue | 20.3B | 17.7B | 18.1B | 13.9B |
Gross profit | 11.5B | 13.7B | 9.4B | 9.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 7.8B | 3.1B | 2.0B | 951M |
Operating income | 614.1M | 7.8B | 4.9B | 6.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 11.1M | 11.1M | 10.9M | 10.9M |
Other income expense | — | — | — | — |
Pretax income | 3.7B | 10.6B | 7.4B | 8.9B |
Tax provision | 793.9M | 2.9B | 1.9B | 2.2B |
Net income | 3.3B | 8.1B | 5.9B | 7.0B |
Basic EPS | — | 20.0 | 14.5 | 17.3 |
Diluted EPS | — | 20.0 | 14.5 | 17.3 |
Basic average shares | — | 403.3M | 403.4M | 403.4M |
Diluted average shares | — | 403.3M | 403.4M | 403.4M |
EBITDA | 4.0B | 11.0B | 7.6B | 9.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |